Enveda Biosciences’ $51 Million Equity Financing

Gunderson Dettmer represented Enveda Biosciences on the deal.Enveda Biosciences, a drug discovery and development company, announced the additional $51 million equity financing, adding to the $68 million…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now